Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-11-04

Clinical Trial Update: A Study for Adolescents With Fibromyalgia Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in adolescents with fibromyalgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 4 | Status: WITHDRAWN